Keyphrases
Cutaneous T-cell Lymphoma
100%
Monotherapy
100%
Complete Remission
100%
Psoralen
100%
UV-A
100%
Mycosis Fungoides
80%
Baseline Characteristics
40%
Disease-free Survival
40%
Actuarial Survival
40%
Stage IB
40%
Effective Treatment
20%
Group-based
20%
Survival Rate
20%
Disease-free
20%
Long-term Survival
20%
Late Relapse
20%
Referral Center
20%
Treatment Duration
20%
Single Center
20%
No Significant Difference
20%
Overall Survival Rate
20%
Kaplan-Meier
20%
Cutaneous Malignancy
20%
Disease-free Interval
20%
Maintenance Therapy
20%
Cutaneous Lymphoma
20%
Follow-up Time
20%
Survival Curve
20%
Curability
20%
Long-term Remission
20%
Retrospective Cohort Analysis
20%
Photodamage
20%
Acute Photodamage
20%
Clinical Stage IA
20%
Disease Eradication
20%
Medicine and Dentistry
Monotherapy
100%
Mycosis fungoides
100%
Psoralen
100%
Cutaneous T Cell Lymphoma
100%
Diseases
100%
Survival Rate
75%
Disease Free Survival
50%
Overall Survival
25%
Cohort Analysis
25%
Long Term Survival
25%
Clinical Stage
25%
Maintenance Therapy
25%
Cutaneous Lymphoma
25%
Patient Referral
25%
Cancer
25%
Pharmacology, Toxicology and Pharmaceutical Science
Remission
100%
Cutaneous T Cell Lymphoma
100%
Monotherapy
100%
Psoralen
100%
Mycosis fungoides
66%
Diseases
66%
Survival Rate
50%
Disease Free Survival
33%
Elimination
16%
Overall Survival
16%
Long Term Survival
16%
Skin Lymphoma
16%